title: Interrupting IL-6-receptor signaling improves atopic dermatitis but associates with bacterial superinfection.
authors.forename: Alexander A
authors.initials: AA
authors.lastname: Navarini
authors.forename: Lars E
authors.initials: LE
authors.lastname: French
authors.forename: Günther F L
authors.initials: GF
authors.lastname: Hofbauer
mesh_terms: D000328:Adult; D018926:Anti-Allergic Agents / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D003876:Dermatitis, Atopic / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D008297:Male; D019947:Receptors, Interleukin-6 / Q000037:antagonists & inhibitors; D015163:Superinfection / Q000150:complications*; D055815:Young Adult
chemical_list: D018926:Anti-Allergic Agents; D061067:Antibodies, Monoclonal, Humanized; D019947:Receptors, Interleukin-6; C502936:tocilizumab